M2 Archive: Preview
You haven't logged in. If you have archive credits in your account, please log in now to use them. If not, you can buy credits in our shopping area.
SurModics Inc licenses nanotechnology drug delivery system from PharmaSol GmbH
SurModics Inc (Nasdaq:SRDX), a provider of surface modification and drug delivery technologies to the healthcare industry, reported on 14 July that the company's subsidiary, Brookwood Pharmaceuticals has acquired the license to lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany....If you want to view the full text, you must first purchase archive credits.
Return to Archives
New Search